AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Radnostix, Inc.

$0.06 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.06
Day Range
$0.06$0.06
Year Range
$0.05$0.11
Market Cap
31.75M
AVG Volume
50.69K
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
01M2M3M4M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q22.67M
26 Q12.38M
25 Q42.9M
25 Q33.28M
25 Q23.66M
25 Q13.24M
24 Q43.9M
24 Q33.92M
24 Q23.17M
24 Q12.9M
Net Income (USD)
-1T-750B-500B-250B0250B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-882K
26 Q1-1.35M
25 Q4-908B
25 Q3-203.6K
25 Q2-160.78K
25 Q1-112.69K
24 Q4245.82K
24 Q3150.25K
24 Q2-233.44K
24 Q1-154.05K
Operating Income (USD)
-1.5M-1M-500K0500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-834.25K
26 Q1-1.31M
25 Q4-574.92K
25 Q3-181.41K
25 Q2-134.84K
25 Q1-65.02K
24 Q4273.62K
24 Q3179.6K
24 Q2-180.12K
24 Q1-266.2K
EBITDA (USD)
-1.5M-1M-500K0500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-704.5K
26 Q1-1.18M
25 Q4-223.74K
25 Q3-32.46K
25 Q221.94K
25 Q167.98K
24 Q4446.43K
24 Q3345.01K
24 Q2-36.6K
24 Q144.85K
Cash Flows (USD)
-750K-500K-250K0250K500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-613.56K
26 Q1-277.62K
25 Q4130.36K
25 Q3-164.42K
25 Q2254.07K
25 Q1-134K
24 Q4-383.34K
24 Q3227.25K
24 Q2-167.86K
24 Q1241.52K
EPS (USD)
-2000-1500-1000-500050024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0
26 Q1-0
25 Q4-1723.63
25 Q3-0
25 Q2-0
25 Q1-0
24 Q40
24 Q30
24 Q2-0
24 Q1-0
Expenses (USD)
02T4T6TR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q21.01M
26 Q11.37M
25 Q44.17T
25 Q31.03M
25 Q22.34M
25 Q12.23M
24 Q42.5M
24 Q31.25M
24 Q21.28M
24 Q11.36M
Cash & Debt (USD)
0500B1T1.5T2TCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q21.2M
26 Q11.35M
25 Q41.7T
25 Q31.65M
25 Q21.86M
25 Q11.65M
24 Q41.95M
24 Q32.37M
24 Q22.19M
24 Q12.37M
Debt ratios
-20000000-15000000-10000000-50000000500000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Debt ratios by quarter
PeriodDebt ratios
26 Q2-3.75
26 Q1-5.27
25 Q4-18901913.03
25 Q36.14
25 Q23.36
25 Q13.96
24 Q42.94
24 Q314.44
24 Q2-17.11
24 Q1-38.01
Margins
-50%0%50%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Margins by quarter
PeriodMargins
26 Q26.67%
26 Q1-6.17%
25 Q494.87%
25 Q323.78%
25 Q258.59%
25 Q162.74%
24 Q432.56%
24 Q335.03%
24 Q233.31%
24 Q131.87%
Return on Capital
-30000000%-20000000%-10000000%0%10000000%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Return on Capital by quarter
PeriodReturn on Capital
26 Q2-46.61%
26 Q1-50.94%
25 Q4-24588782.36%
25 Q3-4.97%
25 Q2-3.77%
25 Q1-2.6%
24 Q45.65%
24 Q33.72%
24 Q2-6.1%
24 Q1-3.82%
Shares Outstanding
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2529.12M
26 Q1528.46M
25 Q4526.79M
25 Q3528.09M
25 Q2527.36M
25 Q1524.08M
24 Q4522.29M
24 Q3523.14M
24 Q2523.42M
24 Q1520.17M
Book Value Per Share (USD)
000.010.010.0124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20
26 Q10.01
25 Q40.01
25 Q30.01
25 Q20.01
25 Q10.01
24 Q40.01
24 Q30.01
24 Q20.01
24 Q10.01
Total Assets (USD)
05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
INIS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q216.65M
26 Q117.19M
25 Q417.84M
25 Q317.85M
25 Q217.51M
25 Q117.57M
24 Q417.16M
24 Q316.7M
24 Q215.92M
24 Q116.82M
Employee Count
02040602016201720182019202020212022202320242025
INIS Employee Count by quarter
PeriodEmployee Count
202544
202441
202339
202232
202130
202030
201937
201832
201730
201628
PE Ratio
0100020003000med 42.32Jan 22Jun 22Sep 22Jan 23Apr 23Jul 25Nov 25
INIS PE Ratio by quarter
PeriodPE Ratio
Nov 25387.16
Oct 25430.17
Oct 25215.09
Oct 25236.6
Oct 25230.57
Oct 25258.1
Sep 25274.45
Sep 25260.9
Sep 25288.04
Sep 25301.12
Aug 25344.14
Aug 25382.43
Aug 25378.98
Aug 251117.84
Aug 251059.58
Jul 251118.36
Jul 251018.12
Jul 25881.67
Jul 25755.72
Jun 25733.68
Jun 25624.52
Jun 25587.78
Jun 25745.22
May 25548.95
May 25519.56
May 25524.81
May 252741.2
May 252741.2
May 23180.86
May 23203
Apr 23147.64
Apr 23147.64
Apr 23151.92
Apr 23136.2
Mar 2338.33
Mar 2345.63
Mar 2339.69
Mar 2349.46
Mar 2349.46
Feb 2349.46
Feb 2345.13
Feb 2346.99
Feb 2351.81
Jan 2346
Jan 2353.17
Jan 2340.8
Jan 2342.04
Dec 2240.19
Dec 2244.88
Dec 2239.57
Dec 2242.35
Dec 2250.7
Nov 2249.46
Nov 2249.46
Nov 2220.13
Nov 2221.7
Oct 2226.9
Oct 2223
Oct 2221.65
Oct 2221.59
Sep 2218.94
Sep 2228.47
Sep 2236.8
Sep 2232.47
Sep 2236.26
Aug 2234.1
Aug 2236.26
Aug 2236.95
Aug 2234.84
Jul 2239.06
Jul 2238
Jul 2230.61
Jul 2239.06
Jul 2240.59
Jun 2244.34
Jun 2240.64
Jun 2242.23
Jun 2242.23
May 2244.76
May 2236.95
Mar 2239.95
Mar 2238.07
Mar 2238.07
Mar 2240.86
Feb 2240.06
Feb 2239.34
Feb 2238.07
Feb 2242.3
Jan 2242.3
Jan 2238.07
Jan 2239.34
Jan 2240.61
Dec 2138.07
Dec 2142.3
Dec 2142.3
Dec 2142.3
Dec 2129.61
Nov 2133.84
Nov 2142.3
Nov 2138.07
Free Cash Flow Yield
-4%-2%0%2%4%med -0.16%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
INIS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2.82%
Sep 26-2.86%
Sep 26-2.91%
Aug 26-2.94%
Aug 26-2.62%
Aug 26-2.5%
Aug 26-0.17%
Jul 26-0.16%
Jul 26-0.19%
Jul 26-0.16%
Jul 26-0.16%
Jul 26-0.16%
Jun 26-0.15%
Jun 26-0.15%
Jun 26-0.16%
Jun 26-0.15%
May 26-0.13%
May 26-0.15%
May 260.19%
May 260.19%
May 260.21%
Apr 260.21%
Apr 260.2%
Apr 260.19%
Apr 260.2%
Mar 26-1.02%
Mar 26-0.94%
Mar 26-0.95%
Mar 26-0.9%
Feb 26-0.9%
Feb 26-0.95%
Feb 26-0.88%
Feb 26-0.94%
Jan 26-1.16%
Jan 26-1.16%
Jan 26-1.16%
Jan 26-1.16%
Jan 26-1.35%
Dec 25-1.47%
Dec 25-1.47%
Dec 25-1.31%
Dec 25-1.16%
Nov 25-1.35%
Nov 25-1.35%
Nov 25-1.24%
Nov 25-0.08%
Oct 25-0.07%
Oct 25-0.14%
Oct 25-0.12%
Oct 25-0.13%
Oct 25-0.11%
Sep 25-0.11%
Sep 25-0.11%
Sep 25-0.1%
Sep 25-0.1%
Aug 25-0.09%
Aug 25-0.08%
Aug 25-0.08%
Aug 25-0.82%
Aug 25-0.87%
Jul 25-0.82%
Jul 25-0.9%
Jul 25-1.04%
Jul 25-1.21%
Jun 25-1.25%
Jun 25-1.47%
Jun 25-1.56%
Jun 25-1.23%
May 25-1.67%
May 25-1.77%
May 25-1.75%
May 25-0.35%
May 25-0.35%
Apr 252.56%
Apr 252.29%
Apr 252.5%
Apr 252.5%
Mar 252.3%
Mar 252.27%
Mar 252.36%
Mar 252.12%
Feb 252.12%
Feb 252.16%
Feb 251.96%
Feb 252.43%
Jan 252.67%
Jan 252.1%
Jan 252.22%
Jan 252.5%
Jan 253.21%
Dec 243.22%
Dec 243.34%
Dec 243.17%
Dec 243.17%
Nov 243%
Nov 243.08%
Nov 243.74%
Nov 24-2.55%
Nov 24-2.27%
Oct 24-2.63%
Price to Sales
1234med 2.54Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
INIS Price to Sales by quarter
PeriodPrice to Sales
Sep 262.92
Sep 262.88
Sep 262.83
Aug 262.8
Aug 263.15
Aug 263.3
Aug 262.75
Jul 263.03
Jul 262.49
Jul 263.04
Jul 262.89
Jul 263.03
Jun 263.11
Jun 263.15
Jun 263.03
Jun 263.07
May 263.63
May 263.25
May 263.55
May 263.43
May 263.11
Apr 263.11
Apr 263.35
Apr 263.54
Apr 263.28
Mar 262.99
Mar 263.22
Mar 263.19
Mar 263.38
Feb 263.38
Feb 263.19
Feb 263.46
Feb 263.23
Jan 262.63
Jan 262.63
Jan 262.63
Jan 262.63
Jan 262.25
Dec 252.06
Dec 252.07
Dec 252.33
Dec 252.63
Nov 252.25
Nov 252.25
Nov 252.46
Nov 253.22
Oct 253.58
Oct 251.79
Oct 251.97
Oct 251.92
Oct 252.15
Sep 252.29
Sep 252.17
Sep 252.4
Sep 252.51
Aug 252.87
Aug 253.18
Aug 253.16
Aug 253.92
Aug 253.72
Jul 253.92
Jul 253.57
Jul 253.09
Jul 252.65
Jun 252.57
Jun 252.19
Jun 252.06
Jun 252.61
May 251.93
May 251.82
May 251.84
May 251.69
May 251.69
Apr 251.75
Apr 251.95
Apr 251.79
Apr 251.79
Mar 251.95
Mar 251.97
Mar 251.89
Mar 252.11
Feb 252.11
Feb 252.07
Feb 252.28
Feb 251.84
Jan 251.67
Jan 252.13
Jan 252.01
Jan 251.79
Jan 251.39
Dec 241.39
Dec 241.34
Dec 241.41
Dec 241.41
Nov 241.49
Nov 241.45
Nov 241.19
Nov 241.38
Nov 241.55
Oct 241.34
EV/EBITDA
0255075100125med 56.88Jan 23Apr 23Jan 25May 25Aug 25Dec 25Mar 26
INIS EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 2689.56
Mar 2696.06
Mar 2695.22
Mar 26100.46
Feb 26100.46
Feb 2695.22
Feb 26102.81
Feb 2696.27
Jan 2679.61
Jan 2679.5
Jan 2679.5
Jan 2679.5
Jan 2669.02
Dec 2563.78
Dec 2563.89
Dec 2571.12
Dec 2579.5
Nov 2569.02
Nov 2569.02
Nov 2574.78
Nov 2557.21
Oct 2563.2
Oct 2533.28
Oct 2536.27
Oct 2535.43
Oct 2539.26
Sep 2541.54
Sep 2539.65
Sep 2543.43
Sep 2545.25
Aug 2551.23
Aug 2556.56
Aug 2556.08
Aug 2571.79
Aug 2568.25
Jul 2571.82
Jul 2565.74
Jul 2557.46
Jul 2549.82
Jun 2548.48
Jun 2541.85
Jun 2539.62
Jun 2549.18
May 2537.27
May 2535.48
May 2535.8
May 2532.33
May 2532.33
Apr 2572.2
Apr 2578.91
Apr 2573.65
Apr 2573.65
Mar 2578.78
Mar 2579.57
Mar 2577.06
Mar 2584.11
Feb 2584.17
Feb 2582.86
Feb 2589.83
Feb 2575.36
Jan 2569.7
Jan 2584.7
Jan 2580.88
Jan 2573.51
Jan 2560.49
Dec 2460.36
Dec 2458.65
Dec 2461.01
Dec 2461.08
Nov 2463.65
Nov 2462.33
Nov 2453.91
May 2320.47
May 2322.82
Apr 2316.94
Apr 2316.94
Apr 2317.4
Apr 2315.73
Mar 2311.07
Mar 2313.03
Mar 2311.44
Mar 2314.06
Mar 2314.06
Feb 2314.06
Feb 2312.9
Feb 2313.4
Feb 2314.69
Jan 2313.13
Jan 2315.06
Jan 2311.73
Jan 2312.07
Dec 2211.57
Dec 2212.83
Dec 2211.4
Dec 2212.15
Dec 2214.39
Nov 2214.06
Nov 2214.06
Nov 229.84
Nov 2210.56
Price/Operating Cashflow
0500100015002000med 70.75Nov 24Feb 25Jun 25Sep 25Jan 26Apr 26Aug 26
INIS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Aug 2660.69
Jul 2666.82
Jul 2654.96
Jul 2667.2
Jul 2663.9
Jul 2666.91
Jun 2668.74
Jun 2669.49
Jun 2666.91
Jun 2667.87
May 2680.1
May 2671.69
May 2674.75
May 2672.2
May 2665.54
Apr 2665.58
Apr 2670.53
Apr 2674.65
Apr 2669.1
Mar 26149.8
Mar 26161.47
Mar 26159.96
Mar 26169.37
Feb 26169.37
Feb 26159.96
Feb 26173.58
Feb 26161.85
Jan 26131.92
Jan 26131.73
Jan 26131.73
Jan 26131.73
Jan 26112.92
Dec 25103.51
Dec 25103.69
Dec 25116.68
Dec 25131.73
Nov 25112.92
Nov 25112.92
Nov 25123.27
Nov 2571.84
Oct 2579.83
Oct 2539.91
Oct 2543.9
Oct 2542.79
Oct 2547.9
Sep 2550.93
Sep 2548.41
Sep 2553.45
Sep 2555.88
Aug 2563.86
Aug 2570.97
Aug 2570.33
Aug 25252.3
Aug 25239.16
Jul 25252.42
Jul 25229.8
Jul 25199
Jul 25170.57
Jun 25165.6
Jun 25140.96
Jun 25132.67
Jun 25168.2
May 25123.9
May 25117.27
May 25118.45
May 2536.79
May 2536.79
Apr 2550.68
Apr 2556.57
Apr 2551.95
Apr 2551.95
Mar 2556.45
Mar 2557.14
Mar 2554.94
Mar 2561.13
Feb 2561.18
Feb 2560.03
Feb 2566.15
Feb 2553.45
Jan 2548.49
Jan 2561.65
Jan 2558.3
Jan 2551.83
Jan 2540.4
Dec 2440.29
Dec 2438.79
Dec 2440.87
Dec 2440.92
Nov 2443.18
Nov 2442.02
Nov 2434.63
Aug 241288.86
Aug 241370.36
Jul 241137.23
Jul 241364.67
Jul 241497.35
Jul 241497.35
Jun 241137.23
Jun 241412.06
Jun 241516.3
Price to Book
05101520med 8.61Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
INIS Price to Book by quarter
PeriodPrice to Book
Sep 2617.34
Sep 2617.08
Sep 2616.78
Aug 2616.64
Aug 2618.68
Aug 2619.57
Aug 2612.68
Jul 2613.96
Jul 2611.48
Jul 2614.04
Jul 2613.35
Jul 2613.98
Jun 2614.36
Jun 2614.52
Jun 2613.98
Jun 2614.18
May 2616.73
May 2614.98
May 2612.55
May 2612.13
May 2611.01
Apr 2611.01
Apr 2611.85
Apr 2612.54
Apr 2611.61
Mar 2610.26
Mar 2611.06
Mar 2610.96
Mar 2611.6
Feb 2611.6
Feb 2610.96
Feb 2611.89
Feb 2611.09
Jan 269.04
Jan 269.03
Jan 269.03
Jan 269.03
Jan 267.74
Dec 257.09
Dec 257.1
Dec 257.99
Dec 259.03
Nov 257.74
Nov 257.74
Nov 258.45
Nov 2511.13
Oct 2512.36
Oct 256.18
Oct 256.8
Oct 256.63
Oct 257.42
Sep 257.89
Sep 257.5
Sep 258.28
Sep 258.65
Aug 259.89
Aug 2510.99
Aug 2510.89
Aug 2512.86
Aug 2512.19
Jul 2512.87
Jul 2511.71
Jul 2510.14
Jul 258.7
Jun 258.44
Jun 257.19
Jun 256.76
Jun 258.57
May 256.32
May 255.98
May 256.04
May 255.41
May 255.41
Apr 255.69
Apr 256.35
Apr 255.83
Apr 255.83
Mar 256.34
Mar 256.42
Mar 256.17
Mar 256.86
Feb 256.87
Feb 256.74
Feb 257.43
Feb 256
Jan 255.45
Jan 256.92
Jan 256.55
Jan 255.82
Jan 254.54
Dec 244.52
Dec 244.36
Dec 244.59
Dec 244.6
Nov 244.85
Nov 244.72
Nov 243.89
Nov 244.37
Nov 244.91
Oct 244.24
Radnostix, Inc.
INIS
Stockpicker

Video analysis: INIS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: INIS

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

prnewswire.com · 13 Aug 2026

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

IDAHO FALLS, Idaho, Aug. 13, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a manufacturer of radioisotope-focused technologies for medical, industrial, and research applications, today announced its financial results for the second quarter and six months ended June 30, 2026 and the filing of its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. Second Quarter and First Half 2026 Financial and Operational Summary Total revenue for the three months ended June 30, 2026 was $2.67 million, a 27% decrease from $3.66 million in the prior-year period.

Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

prnewswire.com · 2 Jul 2026

Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

IDAHO FALLS, Idaho, July 2, 2026 /PRNewswire/ -- Radnostix, Inc. (OTCQB: INIS) ("Radnostix" or the "Company"), a leader in radioisotope production and nuclear medicine solutions, today announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA® System technology platform, ELLEXA® Explorer software and associated intellectual property. The product line was originally developed to identify, improve dosimetry of, and reduce the frequency of extravasations of IV administered radiopharmaceuticals.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.